Oxygen self-supplying nanoradiosensitizer activates cGAS-STING pathway to enhance radioimmunotherapy of triple negative breast cancer [Journal of Controlled Release, Volume 376, December 2024, 794–805]

IF 10.5 1区医学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Journal of Controlled Release Pub Date : 2025-06-16 DOI:10.1016/j.jconrel.2025.113958

Xiaofei Wang, Yang Yang, Peng Wang, Qingdong Li, Wenjuan Gao, Yu Sun, Geng Tian, Guilong Zhang, Jianmin Xiao

引用次数: 0

Abstract

This is a note of a temporary Expression of Concern related to the above-mentioned publication.

查看原文本刊更多论文

氧自供纳米放射增敏剂激活cGAS-STING通路增强三阴性乳腺癌的放射免疫治疗[j] . Journal of control Release, vol . 376, December 2024, 794-805。

这是一份与上述出版物有关的临时关注表示的说明。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Controlled Release 医学-化学综合

CiteScore

18.50

自引率

5.60%

发文量

700

审稿时长

39 days

期刊介绍： The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.